Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults
- 1 December 1990
- Vol. 8 (6) , 577-580
- https://doi.org/10.1016/0264-410x(90)90012-b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgRThe Lancet, 1988
- Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidatesNature, 1984
- A Recombinant Live Oral Cholera VaccineNature Biotechnology, 1984
- Magnitude, Kinetics, and Duration of Vibriocidal Antibody Responsesin North Americans after Ingestion of Vibrio choleraeThe Journal of Infectious Diseases, 1982
- Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunityTransactions of the Royal Society of Tropical Medicine and Hygiene, 1979